Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1628
This examiner grants 33% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17275609 | PYRIMIDINYL-HETEROARYLOXY-NAPHTHYL COMPOUNDS AND METHODS OF USE | Final Rejection | Genentech, Inc. |
| 17281714 | ALDEHYDE CROSSLINKING, PROTEIN BASED TISSUE SCAFFOLDS, AND USES THEREOF | Non-Final OA | University of Florida Research Foundation, Inc. |
| 18003807 | COMPOUNDS AND METHODS OF PROMOTING OLIGODENDROCYTE PRECURSOR DIFFERENTIATION | Non-Final OA | The Cleveland Clinic Foundation |
| 17761902 | MLL1 INHIBITORS AND ANTI-CANCER AGENTS | Non-Final OA | NOVARTIS AG |
| 18141128 | INDUCTION OF IMMUNE TOLERANCE BY USING METHOTREXATE | Final Rejection | Genzyme Corporation |
| 18512177 | CHIRAL OR RACEMIC PYRIMIDINE-FUSED DIAZEPINONE DERIVATIVES, PREPARATION METHOD, AND APPLICATION THEREOF | Non-Final OA | SUN YAT-SEN UNIVERSITY |
| 17558402 | Polyphenols as Modulators of Platelet Function | Non-Final OA | The Brigham and Women's Hospital, Inc. |
| 18794153 | Methods for Treating Traumatic Brain Injury | Non-Final OA | The Government of the United States, as Represented by the Secretary of the Army |
| 18263293 | TYK2 INHIBITOR COMPOUND CONTAINING BICYCLIC RING | Final Rejection | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. |
| 18508992 | TRAZODONE ORAL SOLUTION | Final Rejection | OWP Pharmaceuticals, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy